Resultados da pesquisa - (((((("eo open") OR ("eso opens"))) OR ("esmo open"))) OR ("do open"))

Pesquisas alternativas:
"eso opens" » "best opens" (Expandir a Pesquisa), "o opens" (Expandir a Pesquisa), "so open" (Expandir a Pesquisa)
"eo open" » "neo open" (Expandir a Pesquisa), "ao open" (Expandir a Pesquisa), "o open" (Expandir a Pesquisa)
"do open" » "two open" (Expandir a Pesquisa), "oto open" (Expandir a Pesquisa)

1

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

Por Zielinski, Christoph C, Pinto, Carmine
Publicado no ESMO Open (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

ESMO Open—Cancer Horizons and the future of oncology

ESMO Open—Cancer Horizons and the future of oncology

Por Zielinski, Christoph C
Publicado no ESMO Open (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

CSCO joins ESMO Open—Cancer Horizons

CSCO joins ESMO Open—Cancer Horizons

Por Zielinski, Christoph C, Wu, Yi-Long
Publicado no ESMO Open (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

ESMO Open: news in breast cancer 2019

ESMO Open: news in breast cancer 2019

Por Lambertini, Matteo
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

Por Ohe, Yuichiro, Zielinski, Christoph
Publicado no ESMO Open (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

ESMO Open special series on new emerging targets in cancer immunotherapy

ESMO Open special series on new emerging targets in cancer immunotherapy

Por Lambertini, Matteo
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

Por Morgan, Gilberto, Preusser, Matthias, Zielinski, Christoph
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

One year of ESMO Open: Cancer Horizons—where are we going from here?

One year of ESMO Open: Cancer Horizons—where are we going from here?

Por Zielinski, Christoph
Publicado no ESMO Open (2017)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Por Preusser, Matthias
Publicado no ESMO Open (2019)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion

Por Burke, Patrick W, Hoelzer, Dieter, Park, Jae H, Schmiegelow, Kjeld, Douer, Dan
Publicado no ESMO Open (2020)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

Por Banerjee, Susana, Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N, Oaknin, Ana, Ray-Coquard, Isabelle
Publicado no ESMO Open (2020)

“... with bevacizumab in homologous recombination deficiency-positive-associated advanced ovarian cancer. An ESMO Open...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

Por Awada, Ahmad, Gligorov, Joseph, Jerusalem, Guy, Preusser, Matthias, Singer, Christian, Zielinski, Christoph
Publicado no ESMO Open (2019)

“...In December 2017, ESMO Open—Cancer Horizons convened a round-table discussion on the background...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Desafios do Open Design

Desafios do Open Design

Por Rodrigo Argenton Freire, Evandro Ziggiatti Monteiro, Claudio Lima Ferreira
Publicado em 2018-11-01

Obter o texto integral

Artigo

14

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

Por Lambertini, Matteo, Preusser, Matthias, Zielinski, Christoph C
Publicado no ESMO Open (2019)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

Por Lamarca, A., Foster, L., Satyadas, T., Siriwardena, A., Valle, J.W.
Publicado no ESMO Open (2021)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Adoção do Open Peer Review

Adoção do Open Peer Review

Por Alketa Peci
Publicado no Revista de Administração Pública - RAP (2022)

Obter o texto integral

Artigo

17

How do Openers Contribute to Student Learning?

How do Openers Contribute to Student Learning?

Por Amber ZERTUCHE, Libby GERARD, Marcia C. LINN
Publicado em 2012-10-01

Obter o texto integral

Artigo

18

Criptografia digital: implementação do OpenPGP

Criptografia digital: implementação do OpenPGP

Por Miranda, Ian de Castro de
Publicado em 2018

“... leitores compreenderem o funcionamento do OpenPGP. ...”
Obter o texto integral

Trabalho de conclusão de graduação

19

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Por Peleg Hasson, S., Brezis, M.R., Shachar, E., Shachar, S.S., Wolf, I., Sonnenblick, A.
Publicado no ESMO Open (2021)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]

Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]

Por Shi, L., Xu, C., Ma, Y., Ou, Q., Wu, X., Lu, S., Shao, Y., Guo, R., Kong, J.
Publicado no ESMO Open (2021)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
5
6
7
8
9
10
11
Seguinte
[46]